Tag: surface modification
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
Flow diverting, stenting and beyond—HPC technology offers “limitless” potential in neurointervention
This advertorial is sponsored by phenox.
Following the publication of a study assessing the use of Hydrophilic Polymer Coating (HPC) technology with the p64 MW...
ESMINT 2021: COATING study “badly needed” to assess surface modification of...
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
phenox launches p64 MW Flow modulation device with HPC coating technology
phenox has announced the European launch of the new p64 MW Flow modulation device, intended for the treatment of intracranial aneurysms. The device received...
Surface modification: From bench to clinical practice
Demetrius Lopes has been working on the surface modification of stents and flow diverters, given that thromboembolic and antiplatelet-related complications represent the majority of...
